New research finds MDMA effective in treating severe PTSD
Mental Health Weekly September 25, 2023 DOI: 10.1002/mhw.33794
Summary
AI-generated from the abstractA phase 3 randomized, placebo-controlled trial found that MDMA-assisted therapy reduces symptoms in people with moderate to severe post-traumatic stress disorder (PTSD). The treatment showed improvement across a diverse group of individuals with severe PTSD. The results were published in Nature Medicine.
Study at a glance
| Characteristics | Randomized controlled trial Peer reviewed |
|---|---|
| Population | Individuals with moderate to severe PTSD |
| Key finding | MDMA-assisted therapy reduced symptoms in people with moderate to severe PTSD. |
Abstract
The third part of a new study assessing MDMA‐assisted therapy, a psychedelic drug also known as Ecstasy, has revealed improvement in diverse individuals suffering with severe post‐traumatic stress disorder (PTSD). The study, “MDMA‐assisted therapy for moderate to severe PTSD: a randomized, placebo‐controlled phase 3 trial,” published Sept. 14 in Nature Medicine.